anti-BARX Homeobox 2 (BARX2) Antibodies

Mouse (Murine) BARX Homeobox 2 (BARX2) interaction partners

1. Barx2 and Pax7 regulate the canonical Wnt target gene Axin2, which mediates critical feedback to terminate the transcriptional response to Wnt signals.

2. antagonism between Barx2 and Pax7 in regulation of Wnt signaling may help mediate the switch from myoblast proliferation to differentiation.

3. Barx2 is an important regulator of muscle growth and repair that acts via the control of satellite cell proliferation and differentiation.

4. data suggest a functional network involving Barx2, Fgf10 and matrix metalloproteinases that plays an essential role in regulating branching morphogenesis of the ocular glands.

5. Study show that Barx2 regulates plasticity of immature myofibers and might act as a molecular switch controlling cell differentiation and proliferation.

6. promotes myogenic differentiation and is regulated by myogenic regulatory factors

7. Barx2 homeodomain factor serves as a regulator of hair follicle remodeling (catagen.

8. acts downstream of BMP signaling and in concert with Sox proteins to regulate chondrogenesis

9. BARX2 and estrogen receptor alpha may coordinately regulate cell growth, survival and invasion pathways that are critical to breast cancer progression.

10. Barx2 cooperates with other muscle-expressed transcription factors to regulate the early cytoskeletal remodeling events that underlie efficient myoblast differentiation.

Human BARX Homeobox 2 (BARX2) interaction partners

1. These findings reveal that Barx2 serving as a tumor suppressor gene could decrease cell proliferation, migration, and aerobic glycolysis through inhibiting the Wnt/beta-catenin signaling pathway, and predicts a good prognosis in non-small cell lung carcinoma

2. these findings indicate that reduction or loss of Barx2 dis-inhibits gastric cancer cell proliferation and invasion, and that reduction in Barx2 could serve as an independent prognostic biomarker for poor outcome in gastric cancer patients

3. Down-regulation of Barx2 is associated with advanced clinical factors of colorectal cancer and predicts poor survival.

4. BARX2 can coordinate the expression of a network of genes that influence the growth of tumor cells